Early Results of Radiofrequency Ablation for Treating Molecular Negative Bethesda III Thyroid Nodules
In our single institution study of RFA for patients with molecular negative BIII thyroid nodules, VRRs for BII and BIII nodules were similar at 12 months. RFA appears safe and effective for BIII nodules devoid of molecular alterations, though longer-term follow-up is needed.
Authors
- Melanie Goldfarb (ORCID: https://orcid.org/0000-0002-3929-0354)
- Katherine M. Jackson (ORCID: https://orcid.org/0000-0001-9376-4939)
- Stacey L. Stern
- JE McCabe
- Ariela Edri
Institutions
- Saint John's Health Center (US)
Publication Details
- Journal
- Journal of the American College of Surgeons
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1097/xcs.0000000000001388
- Citations
- 1
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.29